1
|
Larsen EC, Christiansen OB, Kolte AM and
Macklon N: New insights into mechanisms behind miscarriage. BMC
Med. 11:1542013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kwak-Kim J, Agcaoili MS, Aleta L, Liao A,
Ota K, Dambaeva S, Beaman K, Kim JW and Gilman-Sachs A: Management
of women with recurrent pregnancy losses and antiphospholipid
antibody syndrome. Am J Reprod Immunol. 69:596–607. 2013.PubMed/NCBI
|
3
|
Shetty S, Patil R and Ghosh K: Role of
microparticles in recurrent miscarriages and other adverse
pregnancies: A review. Eur J Obstet Gynecol Reprod Biol.
169:123–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hovdenak N and Haram K: Influence of
mineral and vitamin supplements on pregnancy outcome. Eur J Obstet
Gynecol Reprod Biol. 164:127–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Martínez-Zamora MÁ, Cervera R and Balasch
J: Recurrent miscarriage, antiphospholipid antibodies and the risk
of thromboembolic disease. Clin Rev Allergy Immunol. 43:265–274.
2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Saini V, Arora S, Yadav A and
Bhattacharjee J: Cytokines in recurrent pregnancy loss. Clin Chim
Acta. 412:702–708. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
van Mourik MS, Macklon NS and Heijnen CJ:
Embryonic implantation: Cytokines, adhesion molecules, and immune
cells in establishing an implantation environment. J Leukoc Biol.
85:4–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Piccinni MP, Scaletti C, Maggi E and
Romagnani S: Role of hormone-controlled Th1- and Th2-type cytokines
in successful pregnancy. J Neuroimmunol. 109:30–33. 2000.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Chaouat G, Lédée-Bataille N, Zourbas S,
Ostojic S, Dubanchet S, Martal J and Frydman R: Cytokines,
implantation and early abortion: Re-examining the Th1/Th2 paradigm
leads to question the single pathway, single therapy concept. Am J
Reprod Immunol. 50:177–186. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
D'Ippolito S, Tersigni C, Marana R, Di
Nicuolo F, Gaglione R, Rossi ED, Castellani R, Scambia G and Di
Simone N: Inflammosome in the human endometrium: Further step in
the evaluation of the ‘maternal side’. Fertil Steril.
105:111–118.e1-e4. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time PCR and the 2(-Delta
Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
12
|
Paszkowski AS, Rau B, Mayer JM, Möller P
and Beger HG: Therapeutic application of caspase
1/interleukin-1beta-converting enzyme inhibitor decreases the death
rate in severe acute experimental pancreatitis. Ann Surg.
235:68–76. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Westermann D, Van Linthout S, Dhayat S,
Dhayat N, Escher F, Bücker-Gärtner C, Spillmann F, Noutsias M, Riad
A, Schultheiss HP and Tschöpe C: Cardioprotective and
anti-inflammatory effects of interleukin converting enzyme
inhibition in experimental diabetic cardiomyopathy. Diabetes.
56:1834–1841. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sereshki N, Gharagozloo M, Ostadi V,
Ghahiri A, Roghaei MA, Mehrabian F, Andalib AA, Hassanzadeh A,
Hosseini H and Rezaei A: Variations in T-helper 17 and regulatory T
cells during the menstrual cycle in peripheral blood of women with
recurrent spontaneous abortion. Int J Fertil Steril. 8:59–66.
2014.PubMed/NCBI
|
15
|
Wang WJ, Hao CF, Yi-Lin, Yin GJ, Bao SH,
Qiu LH and Lin QD: Increased prevalence of T helper 17 (Th17) cells
in peripheral blood and decidua in unexplained recurrent
spontaneous abortion patients. J Reprod Immunol. 84:164–170. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Potdar N, Gelbaya T and Nardo LG:
Endometrial injury to overcome recurrent embryo implantation
failure: A systematic review and meta-analysis. Reprod Biomed
Online. 25:561–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Denny KJ, Woodruff TM, Taylor SM and
Callaway LK: Complement in pregnancy: A delicate balance. Am J
Reprod Immunol. 69:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kokcu A, Yavuz E, Celik H and Bildircin D:
A panoramic view to relationships between reproductive failure and
immunological factors. Arch Gynecol Obstet. 286:1283–1289. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Nakashima A, Shima T, Inada K, Ito M and
Saito S: The balance of the immune system between T cells and NK
cells in miscarriage. Am J Reprod Immunol. 67:304–310. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Jin LP, Fan DX and Li DJ: Regulation of
costimulatory signal in maternal-fetal immune tolerance. Am J
Reprod Immunol. 66:76–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Rock KL, Kataoka H and Lai JJ: Uric acid
as a danger signal in gout and its comorbidities. Nat Rev
Rheumatol. 9:13–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Grebe A and Latz E: Cholesterol crystals
and inflammation. Curr Rheum Rep. 15:3132013. View Article : Google Scholar
|
23
|
Jourdan T, Godlewski G, Cinar R, Bertola
A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC, et
al: Activation of the Nlrp3 inflammasome in infiltrating
macrophages by endocannabinoids mediates beta cell loss in type 2
diabetes. Nat Med. 19:1132–1140. 2013. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Kirwan AM, Lenighan YM, O'Reilly ME,
McGillicuddy FC and Roche HM: Nutritional modulation of metabolic
inflammation. Biochem Soc Trans. 45:979–985. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Peck A and Mellins ED: Plasticity of
T-cell phenotype and function: The T helper type 17 example.
Immunology. 129:147–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lin QD and Qiu LH: Pathogenesis,
diagnosis, and treatment of recurrent spontaneous abortion with
immune type. Front Med China. 4:275–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Druckmann R and Druckmann MA: Progesterone
and the immunology of pregnancy. J Steroid Biochem Mol Biol.
97:389–396. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Cohen RA, Check JH and Dougherty MP:
Evidence that exposure to progesterone alone is a sufficient
stimulus to cause a precipitous rise in the immunomodulatory
protein the progesterone induced blocking factor (PIBF). J Assist
Reprod Genet. 33:221–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Jin LP, Fan DX, Zhang T, Guo PF and Li DJ:
The costimulatory signal upregulation is associated with Th1 bias
at the maternal-fetal interface in human miscarriage. Am J Reprod
Immunol. 66:270–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Raghupathy R, Makhseed M, Azizieh F,
Hassan N, Al-Azemi M and Al-Shamali E: Maternal Th1- and Th2-type
reactivity to placental antigens in normal human pregnancy and
unexplained recurrent spontaneous abortions. Cell Immunol.
196:122–130. 1999. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zenclussen AC: Regulatory T cells in
pregnancy. Springer Semin Immunopathol. 28:31–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wang WJ, Liu FJ, Qu HM, Hao CF, Qu QL,
Xiong-Wang, Bao HC and Wang XR: Regulation of the expression of
Th17 cells and regulatory T cells by IL-27 in patients with
unexplained early recurrent miscarriage. J Reprod Immunol.
99:39–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Mangan MS and Latz E: TAK1ng control: TAK1
restrains NLRP3 activation. J Exp Med. 215:1007–1008. 2018.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Poudel B and Gurung P: An update on cell
intrinsic negative regulators of the NLRP3 inflammasome. J Leukoc
Biol. Jan 26–2018.(Epub ahead of print). View Article : Google Scholar
|
35
|
Dinarello CA: A clinical perspective of
IL-1β as the gatekeeper of inflammation. Eur J Immunol.
41:1203–1217. 2011. View Article : Google Scholar : PubMed/NCBI
|
36
|
Cerretti DP, Kozlosky CJ, Mosley B, Nelson
N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T,
Cannizzaro LA, et al: Molecular cloning of the interleukin-1beta
converting enzyme. Science. 256:97–100. 1992. View Article : Google Scholar : PubMed/NCBI
|
37
|
Thornberry NA, Bull HG, Calaycay JR,
Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner
JR, Aunins J, et al: A novel heterodimeric cysteine protease is
required for interleukin-1beta processing in monocytes. Nature.
356:768–774. 1992. View Article : Google Scholar : PubMed/NCBI
|
38
|
Miura M, Zhu H, Rotello R, Hartwieg EA and
Yuan J: Induction of apoptosis in fibroblasts by IL-1
beta-converting enzyme, a mammalian homolog of the C. elegans cell
death gene ced-3. Cell. 75:653–660. 1993. View Article : Google Scholar : PubMed/NCBI
|
39
|
Martinon F, Burns K and Tschopp J: The
inflammasome: A molecular platform triggering activation of
inflammatory caspases and processing of proIL-beta. Mol Cell.
10:417–426. 2002. View Article : Google Scholar : PubMed/NCBI
|
40
|
Bauernfeind F, Ablasser A, Bartok E, Kim
S, Schmid-Burgk J, Cavlar T and Hornung V: Inflammasomes: Current
understanding and open questions. Cell Mol Life Sci. 68:765–783.
2011. View Article : Google Scholar : PubMed/NCBI
|
41
|
Fernandes-Alnemri T, Yu JW, Datta P, Wu J
and Alnemri ES: AIM2 activates the inflammasome and cell death in
response to cytoplasmic DNA. Nature. 458:509–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Hornung V, Ablasser A, Charrel-Dennis M,
Bauernfeind F, Horvath G, Caffrey DR, Latz E and Fitzgerald KA:
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating
inflammasome with ASC. Nature. 458:514–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
43
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Davis BK, Wen H and Ting JP: The
inflammasome NLRs in immunity, inflammation, and associated
diseases. Annu Rev Immunol. 29:707–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
45
|
Kanneganti TD: Inflammatory bowel disease
and the NLRP3 inflammasome. N Engl J Med. 377:694–696. 2017.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Neudecker V, Haneklaus M, Jensen O,
Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS,
Gerich ME, et al: Myeloid-derived miR-223 regulates intestinal
inflammation via repression of the NLRP3 inflammasome. J Exp Med.
214:1737–1752. 2017. View Article : Google Scholar : PubMed/NCBI
|
47
|
Alijotas-Reig J, Melnychuk T and Gris JM:
Regulatory T cells, maternal-foetal immune tolerance and recurrent
miscarriage: New therapeutic challenging opportunities. Med Clin
(Barc). 144:265–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
48
|
Saito S, Nakashima A, Myojo-Higuma S and
Shiozaki A: The balance between cytotoxic NK cells and regulatory
NK cells in human pregnancy. J Reprod Immunol. 77:14–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
49
|
Zhu XY, Zhou YH, Wang MY, Jin LP, Yuan MM
and Li DJ: Blockade of CD86 signaling facilitates a Th2 bias at the
maternal-fetal interface and expands peripheral CD4+CD25+
regulatory T cells to rescue abortion-prone fetuses. Biol Reprod.
72:338–345. 2005. View Article : Google Scholar : PubMed/NCBI
|
50
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005. View
Article : Google Scholar : PubMed/NCBI
|
51
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|